Register Now

     First Name:
     Last Name:
     Dept/BOX/ MS:
     Zip/Postal Code:
     Phone: - -
     Fax: - -
     Company URL:

How many employees are in your entire organization?
IBM and affiliates may use the information you have provided to keep you informed about IBM products, services and offerings.
 No, do not send me e-mail.
 No, do not call.
 No, do not send me postal mail.
Register Now

IBM Privacy Policy


Bookmark and Share

An InformationWeek Webcast:

Beyond Jeopardy!: The Business Implications of IBM Watson

Duration: 60 Minutes

IBM Watson, named after IBM founder Thomas J. Watson, was built by a team of IBM scientists who set out to accomplish a grand challenge -- build a computing system that rivals a human’s ability to answer questions posed in natural language with speed, accuracy and confidence. IBM Watson passed its first test on Jeopardy! in February 2011, but the real test will be in applying the underlying systems, data management and analytics technology in business and across different industries.

Moderated by Stephen Baker, author of Final Jeopardy: Man vs Machine and the Quest to Know Everything, and featuring a panel of IBM business and research executives, this webcast will delve into the present and future business implications of the DeepQA technology behind Watson.

Topics include:

  • Overview of IBM Watson, Jeopardy! The IBM Challenge, and DeepQA technology
  • Business implications of Watson in the areas of
    • Industry transformation, including healthcare
    • Data management and analytics
    • Workload optimized systems

Featured Speakers:

  • Stephen Baker, Author of Final Jeopardy: Man vs Machine and the Quest to Know Everything
  • David Ferrucci, Principal Investigator, DeepQA/Watson Project, IBM Research
  • Tom Rosamilia, General Manager, IBM Power and z Systems
  • Arvind Krishna, General Manager, IBM Information Management
  • Dan Pelino, General Manager, IBM Healthcare and Life Sciences Industry


UBM Tech - 600 Community Drive, Manhasset, New York 11030 - Privacy Statement